• Mario Testini, Rinaldo Marzaioli, Germana Lissidini, Agostino Lippolis, Francesco Logoluso, Angela Gurrado, Domenica Lardo, Elisabetta Poli, and Giuseppe Piccinni.
• Section of General and Thoracic Surgery, Department of Applications in Surgery of Innovative Technologies, University Medical School of Bari, Policlinico, Piazza G. Cesare 11, 70124, Bari, Italy. mario.testini@chirgen2.uniba.it
• Langenbecks Arch Surg. 2009 Sep 1;394(5):837-42.

BackgroundThe objective of this study was to compare the effectiveness of FloSeal matrix hemostatic agent with hemostatic surgical procedures and Tabotamp in thyroid surgery.MethodsOne hundred fifty-five consecutive total thyroidectomy patients were recruited at our institution between January 2005 and December 2007. Exclusion criteria were applied. Patients were randomized to one of three hemostatic approaches: 49 received surgical procedures only, and 52 received oxidized regenerated cellulose patch (Tabotamp Fibrillar 2.5 x 5 cm) and 54 FloSeal (5,000 U/5 mL). The same surgeon performed all operations.ResultsMean operating time was reduced in the FloSeal group (105 min) vs. surgical (133 min, p = 0.02) and vs. Tabotamp (122 min, p = 0.0003). Also, wound drain removal occurred earlier with FloSeal (p = 0.006 vs. surgical; p = 0.008 vs. Tabotamp) resulting in shorter postoperative hospital stay in the FloSeal group (p = 0.02 vs. surgical; p = 0.002 vs. Tabotamp).ConclusionsFloSeal matrix is an effective additional agent to conventional haemostatic procedures in thyroid surgery.

20 keywords...

hide…